The second example is from engineering tumor cells to overexpress CD40L, resulting in tumor-derived exosomes that overexpress CD40L to promote dendritic cell maturation, resulting in increased T cell proliferation and antitumor activity in vivo (131). This evidence concerns the gene CD40LG and neoplasm.